Navigation Links
Bird flu vaccine protects people and pets
Date:10/19/2008

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against different flu strains and can even be given to birds while they are still in their eggs, allowing the mass vaccination of wild birds.

The emergence of bird flu has posed a major challenge to scientists designing vaccines as it can infect a number of different animals, including birds, pets and people. Now, researchers in the USA have discovered that a vaccine based on a bird flu virus could be used to protect several species against different influenza viruses.

"The world is experiencing a pandemic of influenza in birds caused by an H5N1 virus. Although it has been restricted to Eurasia and some countries in Africa, there is a risk that this virus may spread worldwide," said Professor Daniel Perez from the University of Maryland, USA. "The H5N1 virus also has an unusual expanded host range: not only birds and humans have been infected but also cats, which are usually resistant to influenza. To prepare for a pandemic, it would be ideal to have a vaccine that could be used in multiple animal species."

The researchers found that the central genes or 'backbone' of the H9N2 virus that infects guinea fowl can protect birds and mice against highly pathogenic strains of influenza. They modified the virus to make it less pathogenic and then used it to vaccinate mice. Three weeks after being vaccinated, the mice were infected with the potentially lethal H1N1 virus the same virus that caused the 1918 Spanish flu pandemic. All the vaccinated mice survived with no signs of disease. Vaccinated mice also survived infection with the deadly H5N1 bird flu virus, again showing no signs of disease.

"Our results show that the H9N2 backbone vaccine can be used to protect mice against two different, highly p
'/>"/>

Contact: Lucy Goodchild
press@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. RNA molecules, delivery system improve vaccine responses, effectiveness
2. Childrens National researchers develop novel anti-tumor vaccine
3. Vaccine against HER2-positive breast cancer offers complete protection in lab
4. Clinical trial for new tuberculosis vaccine
5. Syracuse University partners with Serum Institute of India to develop vaccines for children
6. Nano vaccine for hepatitis B shows promise for third world
7. UCF professor develops vaccine to protect against black plague bioterror attack
8. Mobilizing white blood cells to the lung: New discovery could lead to an improved influenza vaccine
9. Prostate cancer vaccines more effective with hormone therapy
10. From foe to friend: Researchers use salmonella as a way to administer vaccines in the body
11. Footrot vaccine closer than ever

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...rch Centre, a partnership of the University of Bri...astal Health Research Institute, have uncovered ne...ells die following a stroke, as well as a possible...tudy were recently published online in Nature Med...ontinue to die even after blood flow has been rest...
(Date:11/20/2009)...read studies about the health benefits of having a...ular level, where amino acids known as cysteines a... when paired up with other cysteines. , Now, res... colleagues in Belgium, have discovered a new anti... research appears in the Nov. 20 issue of the jour...
(Date:11/20/2009)...009) Scientists from the Marine Biogeochemistry a...search Laboratory (NRL) organized and led a team o...c expedition to initiate methane hydrate explorati...ariation of sediment contribution to Arctic climat...r Polar Sea as a research platform, three cross-sh...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
... heart cells in culture to mimic the properties of...t into the mechanisms that spawn irregular heart r...evealed that while electric shocks such as those d...t waves, in some cases they cause them to accelera...opkins University team, led by Nenad Bursac of Duk...
...spectrometry for decades to determine the chemical...d to identify viruses, and never in complex enviro...ns Bloomberg School of Public Health recently demo...potential to be applied for this purpose. Using a ...ed, purified and concentrated a norovirus surrogat...
..., formerly a Senior Research Associate at the Stow...urquié, Ph.D., Stowers Institute Investigator and ...titute, have demonstrated that the long-studied fa...essed in a cyclic fashion during the formation of ...bryo. , The findings, which were published in the...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3Researchers use mass spectrometry to detect norovirus particles 2Stowers scientists demonstrate mechanism of vertebral formation 2
(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)... Promega Corporation and SwitchGear G... DNA-protein interactions. , ...Promega Corporation and SwitchGear Genomics announ...nteractions. Results of a study using the HaloCHIP... demonstrate the ability to correlate DNA binding ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
(Date:11/18/2009)..., BALTIMORE, Nov. 18 Ch...CSBR), an oncology drug development company with a...ting the development and enhancing the value of on...ng agreement with Yale University and Southern Res...or cancer treatment. Scientists from Yale and Sou...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4
...t microRNA-based Diagnostic Tests are Expected to ...Nanogen,s MGB Probe Technology, Rosetta Genomics ...igned, Real-Time PCR Diagnostic Assays That Allo...on of microRNA in Tissues and Body Fluids, REHOVO...1, Rosetta Genomics, Ltd. (NASDQ: ROSG) announced,...
...YORK, Dec. 10 /Xinhua-PRNewswire-FirstCall/ -- Chi...rd: CYIG; hereinafter the,"Company") announced tod...o. Ltd. ("Shandong YCT"), the Company,s wholly-own...a, has been awarded the honor of China,s "Top 100,...euticals sector. The,award was conferred by the Sm...
...ON, Dec. 10 Oxford Finance Corporation and GE,Hea...ounds Sterling 7.5,million senior secured loan to ... the largest venture loans provided to a biotechno...d in Cambridge, England, is one of the largest,pri...ting on the discovery,and development of small mol...
Other Biology Technology:Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 2Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 3Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 4CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise" 2Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 2
Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: